Product Dossier
VARIVAX REFRIGERATED
Product Dossier for VARIVAX REFRIGERATED (live varicella vaccine, Merck Sharp & Dohme). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Merck Sharp & Dohme
- Active ingredient: live varicella vaccine
- Therapeutic area: Infectious Disease
- Related brand: PRIORIX-TETRA
- Related brand: PROQUAD
- Same area: RETROVIR
- Same area: Savacol Antiseptic Mouth & Throat Rinse
What it is
VARIVAX REFRIGERATED is a varicella virus vaccine live powder for injection supplied by Merck Sharp & Dohme.
Regulatory history
VARIVAX REFRIGERATED was first registered on the Australian Register of Therapeutic Goods on 3 January 2003 as a powder for injection in a vial. A variant with a prefilled diluent syringe was registered on 16 March 2005. A further variant with a sterile diluent vial was registered on 30 July 2020.